Hillary B Nguyen1,2,3,4, Alexis M Chavez4, Emily Lipner2,3, Liisa Hantsoo3, Sara L Kornfield3, Robert D Davies4, C Neill Epperson5,6,7. 1. School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA. 2. Penn PROMOTES Research on Sex and Gender in Health, University of Pennsylvania, Philadelphia, PA, USA. 3. Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. 4. Department of Psychiatry, University of Colorado School of Medicine-Anschutz Medical Campus, 13001 E 17th Place, MS F546, Aurora, CO, 80045, USA. 5. Penn PROMOTES Research on Sex and Gender in Health, University of Pennsylvania, Philadelphia, PA, USA. neill.epperson@ucdenver.edu. 6. Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. neill.epperson@ucdenver.edu. 7. Department of Psychiatry, University of Colorado School of Medicine-Anschutz Medical Campus, 13001 E 17th Place, MS F546, Aurora, CO, 80045, USA. neill.epperson@ucdenver.edu.
Abstract
PURPOSE OF REVIEW: With increasing numbers of transgender and gender non-binary individuals presenting for care, knowing how to elucidate the mental health and cognitive outcomes of gender-affirming hormone therapy (GAHT) is necessary. This article reviews the present literature covering GAHT effects on mood, behavioral health, and cognition in these individuals and offers research priorities to address knowledge gaps. RECENT FINDINGS: Although there are some conflicting data, GAHT overwhelmingly seems to have positive psychological effects in both adolescents and adults. Research tends to support that GAHT reduces symptoms of anxiety and depression, lowers perceived and social distress, and improves quality of life and self-esteem in both male-to-female and female-to-male transgender individuals. Clinically, prescribing GAHT can help with gender dysphoria-related mental distress. Thus, timely hormonal intervention represents a crucial tool for improving behavioral wellness in transgender individuals, though effects on cognitive processes fundamental for daily living are unknown. Future research should prioritize better understanding of how GAHT may affect executive functioning.
PURPOSE OF REVIEW: With increasing numbers of transgender and gender non-binary individuals presenting for care, knowing how to elucidate the mental health and cognitive outcomes of gender-affirming hormone therapy (GAHT) is necessary. This article reviews the present literature covering GAHT effects on mood, behavioral health, and cognition in these individuals and offers research priorities to address knowledge gaps. RECENT FINDINGS: Although there are some conflicting data, GAHT overwhelmingly seems to have positive psychological effects in both adolescents and adults. Research tends to support that GAHT reduces symptoms of anxiety and depression, lowers perceived and social distress, and improves quality of life and self-esteem in both male-to-female and female-to-male transgender individuals. Clinically, prescribing GAHT can help with gender dysphoria-related mental distress. Thus, timely hormonal intervention represents a crucial tool for improving behavioral wellness in transgender individuals, though effects on cognitive processes fundamental for daily living are unknown. Future research should prioritize better understanding of how GAHT may affect executive functioning.
Authors: Daphna Joel; Zohar Berman; Ido Tavor; Nadav Wexler; Olga Gaber; Yaniv Stein; Nisan Shefi; Jared Pool; Sebastian Urchs; Daniel S Margulies; Franziskus Liem; Jürgen Hänggi; Lutz Jäncke; Yaniv Assaf Journal: Proc Natl Acad Sci U S A Date: 2015-11-30 Impact factor: 11.205
Authors: Bethany Alice Jones; Emma Haycraft; Walter Pierre Bouman; Nicola Brewin; Laurence Claes; Jon Arcelus Journal: Eur Eat Disord Rev Date: 2018-01-10
Authors: Theodore D Satterthwaite; Simon Vandekar; Daniel H Wolf; Kosha Ruparel; David R Roalf; Chad Jackson; Mark A Elliott; Warren B Bilker; Monica E Calkins; Karthik Prabhakaran; Christos Davatzikos; Hakon Hakonarson; Raquel E Gur; Ruben C Gur Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-12-20 Impact factor: 8.829
Authors: Lajos Simon; Lajos R Kozák; Viktória Simon; Pál Czobor; Zsolt Unoka; Ádám Szabó; Gábor Csukly Journal: PLoS One Date: 2013-12-31 Impact factor: 3.240
Authors: A D Fisher; G Senofonte; C Cocchetti; G Guercio; V Lingiardi; M C Meriggiola; M Mosconi; G Motta; J Ristori; A M Speranza; M Pierdominici; M Maggi; G Corona; F Lombardo Journal: J Endocrinol Invest Date: 2021-10-22 Impact factor: 4.256
Authors: Danyon Anderson; Himasa Wijetunge; Peyton Moore; Daniel Provenzano; Nathan Li; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits Journal: Health Psychol Res Date: 2022-09-23
Authors: Aaren Kettelhut; Emily Bowman; Janelle Gabriel; Brittany Hand; Namal P M Liyanage; Manjusha Kulkarni; Frances Avila-Soto; Jordan E Lake; Nicholas T Funderburg Journal: Front Immunol Date: 2022-06-03 Impact factor: 8.786